Original article
Long-term response to aminopyridines in a cohort of patients with ataxia associated with downbeat nystagmus due to the FGF14 GAA expansion
Respuesta a largo plazo a aminopiridinas en una cohorte de pacientes con ataxia asociada a nistagmo vertical hacia abajo debida a la expansión GAA del gen FGF14
E. Muñoza,b,c,d,
, M. De la Cruz-Pueblaa,c,e, D. Pellerinf,g, C. Painousa,c, M.I. Álvarez-Morac,h,i, M.J. Dicairef, L. Rodríguez-Revengac,h,i, M.C. Danzij, S. Zuchnerj, B. Braisf
Autor para correspondencia
a Parkinson's Disease and Movement Disorders Unit, Neurology Department, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
b Institut de Neurociències, University of Barcelona, Barcelona, Catalonia, Spain
c Fundació de Recerca Clínic Barcelona-Institut de Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Catalonia, Spain
d European Reference Network of Rare Neurological Diseases (ERN-RND), Spain
e Department of Equity in Brain Health, Global Brain Health Institute (GBHI), University of California, San Francisco (UCSF), CA, USA
f Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, QC, Canada
g Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and the National Hospital for Neurology and Neurosurgery, University College London, London, United Kingdom
h Biochemistry and Molecular Genetics Department, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
i Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain
j Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA
Ver más
